SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-13-000012
Filing Date
2013-05-13
Accepted
2013-05-13 16:25:34
Documents
9
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ljpc-10q_20130331.htm 10-Q 271094
2 EX-31.1 ljpc-ex31_2013033047.htm EX-31 12783
3 EX-32.1 ljpc-ex32_2013033048.htm EX-32 7510
  Complete submission text file 0001564590-13-000012.txt   2013094

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ljpc-20130331_pre.xml EX-101.PRE 141744
5 XBRL INSTANCE DOCUMENT ljpc-20130331.xml EX-101.INS 236354
6 XBRL TAXONOMY EXTENSION SCHEMA ljpc-20130331.xsd EX-101.SCH 20849
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ljpc-20130331_cal.xml EX-101.CAL 19064
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ljpc-20130331_def.xml EX-101.DEF 120275
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ljpc-20130331_lab.xml EX-101.LAB 150069
Mailing Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122 858-452-6600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24274 | Film No.: 13837676
SIC: 2836 Biological Products, (No Diagnostic Substances)